We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
-1.53%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$23.8B
AUM Growth
-$2.11B
Cap. Flow
-$941M
Cap. Flow %
-3.95%
Top 10 Hldgs %
24.95%
Holding
1,082
New
165
Increased
347
Reduced
405
Closed
129

Sector Composition

Rank Sector Weight
1 Technology 30.74%
2 Financials 13.54%
3 Consumer Discretionary 13.12%
4 Industrials 11.88%
5 Healthcare 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WOOF icon
651
Petco
WOOF
$725M
$1.39M 0.01%
500,642
-457,316
-48% -$1.27M
EVH icon
652
Evolent Health
EVH
$522M
$1.39M 0.01%
610,102
-1,658,770
-73% -$5.26M
AVNW icon
653
Aviat Networks
AVNW
$263M
$1.39M 0.01%
61,465
-22,352
-27% -$534K
CRK icon
654
Comstock Resources
CRK
$4.03B
$1.39M 0.01%
65,853
-211,403
-76% -$4.5M
OGE icon
655
OGE Energy
OGE
$10.2B
$1.38M 0.01%
+28,841
New +$1.32M
STBA icon
656
S&T Bancorp
STBA
$1.83B
$1.38M 0.01%
32,985
-8,717
-21% -$364K
AVAH icon
657
Aveanna Healthcare
AVAH
$1.98B
$1.36M 0.01%
211,272
-13,686
-6% -$106K
HTB
658
HomeTrust Bancshares
HTB
$815M
$1.36M 0.01%
31,855
+2,494
+8% +$107K
BHE icon
659
Benchmark Electronics
BHE
$3.01B
$1.35M 0.01%
+24,072
New +$1.29M
ALDX icon
660
Aldeyra Therapeutics
ALDX
$93.5M
$1.35M 0.01%
796,816
-171,935
-18% -$753K
UTHR icon
661
United Therapeutics
UTHR
$26.4B
$1.34M 0.01%
2,268
CRAI icon
662
CRA International
CRAI
$1.08B
$1.32M 0.01%
8,184
MRVI icon
663
Maravai LifeSciences
MRVI
$1.04B
$1.3M 0.01%
458,901
+297,809
+185% +$1.01M
EBF icon
664
Ennis
EBF
$540M
$1.3M 0.01%
60,510
-103,905
-63% -$2.1M
RBB icon
665
RBB Bancorp
RBB
$448M
$1.28M 0.01%
59,728
+1,018
+2% +$21.8K
MGNX icon
666
MacroGenics
MGNX
$255M
$1.27M 0.01%
441,143
-459,914
-51% -$981K
SRI icon
667
Stoneridge
SRI
$201M
$1.27M 0.01%
263,679
+7,388
+3% +$50.6K
SPOK icon
668
Spok Holdings
SPOK
$220M
$1.27M 0.01%
116,810
-2,157
-2% -$27.4K
HTO
669
H2O America
HTO
$2.67B
$1.27M 0.01%
21,668
-61
-0.3% -$3.32K
FCPT icon
670
Four Corners Property Trust
FCPT
$2.84B
$1.26M 0.01%
+53,427
New +$1.32M
VRT icon
671
Vertiv
VRT
$117B
$1.26M 0.01%
5,009
-6,196
-55% -$1.38M
CENTA icon
672
Central Garden & Pet Co Class A
CENTA
$2.36B
$1.25M 0.01%
38,571
-9,704
-20% -$309K
AGO icon
673
Assured Guaranty
AGO
$3.73B
$1.25M 0.01%
15,322
MGY icon
674
Magnolia Oil & Gas
MGY
$4.73B
$1.24M 0.01%
39,286
+657
+2% +$17.6K
P
675
Everpure Inc
P
$25B
$1.24M 0.01%
+20,946
New +$1.42M

Similar funds

Jacobs Levy Equity Management's Q1 2026 Portfolio in Review

As of Q1 2026, Jacobs Levy Equity Management held 1,082 positions worth $23.8B, down 8.1% from $25.9B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Jacobs Levy Equity Management withdrew a net $941M in Q1 2026, closing 129 positions and reducing 405 holdings. Its most notable exit was Illumina, an estimated $53.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Jacobs Levy Equity Management opened a new position in Texas Instruments worth $166M.

  • Jacobs Levy Equity Management's largest Q1 2026 buy was Texas Instruments: 857,024 shares worth $166M.
  • Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q1 2026, an estimated $293M increase.
  • Jacobs Levy Equity Management's biggest Q1 2026 reduction was Lam Research, cutting an estimated $284M.
  • Jacobs Levy Equity Management fully exited Illumina in Q1 2026, selling an estimated $53.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 25% of its $23.8B portfolio in Q1 2026.
  • Jacobs Levy Equity Management opened 165 new positions and closed 129 in Q1 2026.
  • Jacobs Levy Equity Management's portfolio value fell 8.1% quarter-over-quarter to $23.8B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.